ECCO position challenged by European drug regulators.
- 1 March 2014
- journal article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 8 (3), 258
- https://doi.org/10.1016/j.crohns.2014.01.022
Abstract
No abstract availableThis publication has 1 reference indexed in Scilit:
- ECCO position statement: The use of biosimilar medicines in the treatment of inflammatory bowel disease (IBD)Journal of Crohn's and Colitis, 2013